nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RXRB—breast cancer	0.266	0.557	CbGaD
Alitretinoin—RARB—breast cancer	0.185	0.386	CbGaD
Alitretinoin—ABCB1—breast cancer	0.0275	0.0575	CbGaD
Alitretinoin—CYP1A2—Anastrozole—breast cancer	0.0274	0.164	CbGbCtD
Alitretinoin—CYP1A2—Toremifene—breast cancer	0.0251	0.15	CbGbCtD
Alitretinoin—ABCB1—Toremifene—breast cancer	0.0219	0.131	CbGbCtD
Alitretinoin—ABCB1—Lapatinib—breast cancer	0.016	0.0959	CbGbCtD
Alitretinoin—CYP1A2—Tamoxifen—breast cancer	0.00916	0.0549	CbGbCtD
Alitretinoin—ABCB1—Vinorelbine—breast cancer	0.00888	0.0532	CbGbCtD
Alitretinoin—ABCB1—Tamoxifen—breast cancer	0.00801	0.048	CbGbCtD
Alitretinoin—ABCB1—Mitoxantrone—breast cancer	0.00781	0.0468	CbGbCtD
Alitretinoin—ABCB1—Gemcitabine—breast cancer	0.0069	0.0413	CbGbCtD
Alitretinoin—CYP1A2—Fluorouracil—breast cancer	0.00675	0.0404	CbGbCtD
Alitretinoin—ABCB1—Paclitaxel—breast cancer	0.00624	0.0374	CbGbCtD
Alitretinoin—ABCB1—Irinotecan—breast cancer	0.00615	0.0369	CbGbCtD
Alitretinoin—ABCB1—Vinblastine—breast cancer	0.00547	0.0328	CbGbCtD
Alitretinoin—ABCB1—Docetaxel—breast cancer	0.00451	0.027	CbGbCtD
Alitretinoin—ABCB1—Doxorubicin—breast cancer	0.00336	0.0201	CbGbCtD
Alitretinoin—ABCB1—Methotrexate—breast cancer	0.00326	0.0195	CbGbCtD
Alitretinoin—CRABP1—nipple—breast cancer	0.00211	0.0439	CbGeAlD
Alitretinoin—CRABP2—nipple—breast cancer	0.00191	0.0397	CbGeAlD
Alitretinoin—CRABP1—embryo—breast cancer	0.00174	0.0362	CbGeAlD
Alitretinoin—RARA—mammary gland—breast cancer	0.00158	0.0329	CbGeAlD
Alitretinoin—CRABP2—embryo—breast cancer	0.00157	0.0328	CbGeAlD
Alitretinoin—RARG—nipple—breast cancer	0.00139	0.029	CbGeAlD
Alitretinoin—CRABP1—skin of body—breast cancer	0.00135	0.0281	CbGeAlD
Alitretinoin—CRABP2—skin of body—breast cancer	0.00122	0.0254	CbGeAlD
Alitretinoin—CRABP1—pituitary gland—breast cancer	0.00115	0.024	CbGeAlD
Alitretinoin—CRABP2—endometrium—breast cancer	0.00115	0.024	CbGeAlD
Alitretinoin—CRABP1—female reproductive system—breast cancer	0.00105	0.022	CbGeAlD
Alitretinoin—CRABP2—pituitary gland—breast cancer	0.00104	0.0217	CbGeAlD
Alitretinoin—CRABP2—adipose tissue—breast cancer	0.00104	0.0216	CbGeAlD
Alitretinoin—CRABP2—female reproductive system—breast cancer	0.000953	0.0199	CbGeAlD
Alitretinoin—RXRA—female reproductive system—breast cancer	0.000949	0.0198	CbGeAlD
Alitretinoin—CRABP2—adrenal gland—breast cancer	0.00093	0.0194	CbGeAlD
Alitretinoin—RXRG—pituitary gland—breast cancer	0.00091	0.019	CbGeAlD
Alitretinoin—RXRG—adipose tissue—breast cancer	0.000906	0.0189	CbGeAlD
Alitretinoin—CRABP1—endocrine gland—breast cancer	0.000892	0.0186	CbGeAlD
Alitretinoin—RARG—skin of body—breast cancer	0.00089	0.0185	CbGeAlD
Alitretinoin—CRABP2—female gonad—breast cancer	0.000867	0.0181	CbGeAlD
Alitretinoin—RXRA—female gonad—breast cancer	0.000863	0.018	CbGeAlD
Alitretinoin—RARB—female reproductive system—breast cancer	0.000852	0.0178	CbGeAlD
Alitretinoin—RARB—adrenal gland—breast cancer	0.000832	0.0173	CbGeAlD
Alitretinoin—RXRG—adrenal gland—breast cancer	0.000813	0.0169	CbGeAlD
Alitretinoin—CRABP2—endocrine gland—breast cancer	0.000806	0.0168	CbGeAlD
Alitretinoin—RXRA—endocrine gland—breast cancer	0.000803	0.0167	CbGeAlD
Alitretinoin—RARA—endometrium—breast cancer	0.000789	0.0164	CbGeAlD
Alitretinoin—Isotretinoin—RXRB—breast cancer	0.00078	0.156	CrCbGaD
Alitretinoin—RARB—female gonad—breast cancer	0.000775	0.0162	CbGeAlD
Alitretinoin—RARG—uterus—breast cancer	0.000773	0.0161	CbGeAlD
Alitretinoin—Vitamin A—ALDH1A1—breast cancer	0.000766	0.153	CrCbGaD
Alitretinoin—RXRB—adrenal gland—breast cancer	0.000764	0.0159	CbGeAlD
Alitretinoin—RARG—adipose tissue—breast cancer	0.000756	0.0158	CbGeAlD
Alitretinoin—Tretinoin—ALDH1A1—breast cancer	0.00074	0.148	CrCbGaD
Alitretinoin—RARA—uterus—breast cancer	0.000727	0.0151	CbGeAlD
Alitretinoin—RARB—endocrine gland—breast cancer	0.000721	0.015	CbGeAlD
Alitretinoin—RARA—pituitary gland—breast cancer	0.000714	0.0149	CbGeAlD
Alitretinoin—RXRB—female gonad—breast cancer	0.000713	0.0148	CbGeAlD
Alitretinoin—RARA—adipose tissue—breast cancer	0.000711	0.0148	CbGeAlD
Alitretinoin—RXRG—endocrine gland—breast cancer	0.000705	0.0147	CbGeAlD
Alitretinoin—RARG—female reproductive system—breast cancer	0.000695	0.0145	CbGeAlD
Alitretinoin—RARG—adrenal gland—breast cancer	0.000678	0.0141	CbGeAlD
Alitretinoin—Acitretin—RXRB—breast cancer	0.000663	0.132	CrCbGaD
Alitretinoin—RXRB—endocrine gland—breast cancer	0.000663	0.0138	CbGeAlD
Alitretinoin—RARA—female reproductive system—breast cancer	0.000654	0.0136	CbGeAlD
Alitretinoin—RARA—adrenal gland—breast cancer	0.000638	0.0133	CbGeAlD
Alitretinoin—RARG—female gonad—breast cancer	0.000633	0.0132	CbGeAlD
Alitretinoin—RARA—bone marrow—breast cancer	0.000617	0.0129	CbGeAlD
Alitretinoin—RARA—female gonad—breast cancer	0.000595	0.0124	CbGeAlD
Alitretinoin—RARA—endocrine gland—breast cancer	0.000553	0.0115	CbGeAlD
Alitretinoin—Isotretinoin—RARB—breast cancer	0.000541	0.108	CrCbGaD
Alitretinoin—RARB—lymph node—breast cancer	0.000498	0.0104	CbGeAlD
Alitretinoin—CYP1A2—nipple—breast cancer	0.000484	0.0101	CbGeAlD
Alitretinoin—Acitretin—RARB—breast cancer	0.00046	0.0917	CrCbGaD
Alitretinoin—Tretinoin—RXRB—breast cancer	0.000448	0.0894	CrCbGaD
Alitretinoin—RARG—lymph node—breast cancer	0.000407	0.00847	CbGeAlD
Alitretinoin—RARA—lymph node—breast cancer	0.000382	0.00797	CbGeAlD
Alitretinoin—Tretinoin—RARB—breast cancer	0.000311	0.062	CrCbGaD
Alitretinoin—CYP1A2—endocrine gland—breast cancer	0.000205	0.00427	CbGeAlD
Alitretinoin—ABCB1—embryo—breast cancer	0.000205	0.00427	CbGeAlD
Alitretinoin—ABCB1—epithelium—breast cancer	0.000167	0.00348	CbGeAlD
Alitretinoin—ABCB1—endometrium—breast cancer	0.00015	0.00312	CbGeAlD
Alitretinoin—ABCB1—uterus—breast cancer	0.000138	0.00288	CbGeAlD
Alitretinoin—ABCB1—pituitary gland—breast cancer	0.000136	0.00283	CbGeAlD
Alitretinoin—ABCB1—adipose tissue—breast cancer	0.000135	0.00281	CbGeAlD
Alitretinoin—ABCB1—female reproductive system—breast cancer	0.000124	0.00259	CbGeAlD
Alitretinoin—ABCB1—adrenal gland—breast cancer	0.000121	0.00252	CbGeAlD
Alitretinoin—ABCB1—bone marrow—breast cancer	0.000117	0.00244	CbGeAlD
Alitretinoin—ABCB1—female gonad—breast cancer	0.000113	0.00235	CbGeAlD
Alitretinoin—ABCB1—endocrine gland—breast cancer	0.000105	0.00219	CbGeAlD
Alitretinoin—Vitamin A—CYP1A1—breast cancer	9.02e-05	0.018	CrCbGaD
Alitretinoin—Tretinoin—CYP1A1—breast cancer	8.71e-05	0.0174	CrCbGaD
Alitretinoin—ABCB1—lymph node—breast cancer	7.26e-05	0.00151	CbGeAlD
Alitretinoin—Acitretin—ALB—breast cancer	7.18e-05	0.0143	CrCbGaD
Alitretinoin—Tretinoin—CYP3A4—breast cancer	5.56e-05	0.0111	CrCbGaD
Alitretinoin—Insomnia—Capecitabine—breast cancer	1.51e-05	8.84e-05	CcSEcCtD
Alitretinoin—Hypoaesthesia—Doxorubicin—breast cancer	1.5e-05	8.83e-05	CcSEcCtD
Alitretinoin—Rash—Fluorouracil—breast cancer	1.5e-05	8.82e-05	CcSEcCtD
Alitretinoin—Dermatitis—Fluorouracil—breast cancer	1.5e-05	8.81e-05	CcSEcCtD
Alitretinoin—Pharyngitis—Doxorubicin—breast cancer	1.5e-05	8.8e-05	CcSEcCtD
Alitretinoin—Paraesthesia—Capecitabine—breast cancer	1.5e-05	8.78e-05	CcSEcCtD
Alitretinoin—Decreased appetite—Docetaxel—breast cancer	1.5e-05	8.78e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Paclitaxel—breast cancer	1.5e-05	8.78e-05	CcSEcCtD
Alitretinoin—Headache—Fluorouracil—breast cancer	1.49e-05	8.77e-05	CcSEcCtD
Alitretinoin—Urinary tract disorder—Doxorubicin—breast cancer	1.49e-05	8.76e-05	CcSEcCtD
Alitretinoin—Oedema peripheral—Doxorubicin—breast cancer	1.49e-05	8.74e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Docetaxel—breast cancer	1.49e-05	8.72e-05	CcSEcCtD
Alitretinoin—Dyspnoea—Capecitabine—breast cancer	1.49e-05	8.72e-05	CcSEcCtD
Alitretinoin—Fatigue—Docetaxel—breast cancer	1.48e-05	8.71e-05	CcSEcCtD
Alitretinoin—Angiopathy—Epirubicin—breast cancer	1.48e-05	8.7e-05	CcSEcCtD
Alitretinoin—Urethral disorder—Doxorubicin—breast cancer	1.48e-05	8.7e-05	CcSEcCtD
Alitretinoin—Nausea—Mitoxantrone—breast cancer	1.48e-05	8.68e-05	CcSEcCtD
Alitretinoin—Nausea—Irinotecan—breast cancer	1.48e-05	8.68e-05	CcSEcCtD
Alitretinoin—Pain—Docetaxel—breast cancer	1.47e-05	8.64e-05	CcSEcCtD
Alitretinoin—Constipation—Docetaxel—breast cancer	1.47e-05	8.64e-05	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—breast cancer	1.47e-05	8.63e-05	CcSEcCtD
Alitretinoin—Dyspepsia—Capecitabine—breast cancer	1.47e-05	8.61e-05	CcSEcCtD
Alitretinoin—Chills—Epirubicin—breast cancer	1.47e-05	8.6e-05	CcSEcCtD
Alitretinoin—Arrhythmia—Epirubicin—breast cancer	1.46e-05	8.57e-05	CcSEcCtD
Alitretinoin—Visual impairment—Doxorubicin—breast cancer	1.46e-05	8.55e-05	CcSEcCtD
Alitretinoin—Asthenia—Paclitaxel—breast cancer	1.46e-05	8.55e-05	CcSEcCtD
Alitretinoin—Decreased appetite—Capecitabine—breast cancer	1.45e-05	8.5e-05	CcSEcCtD
Alitretinoin—Alopecia—Epirubicin—breast cancer	1.44e-05	8.47e-05	CcSEcCtD
Alitretinoin—Nausea—Gemcitabine—breast cancer	1.44e-05	8.45e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Capecitabine—breast cancer	1.44e-05	8.44e-05	CcSEcCtD
Alitretinoin—Fatigue—Capecitabine—breast cancer	1.44e-05	8.43e-05	CcSEcCtD
Alitretinoin—Pruritus—Paclitaxel—breast cancer	1.44e-05	8.43e-05	CcSEcCtD
Alitretinoin—Vision blurred—Methotrexate—breast cancer	1.43e-05	8.41e-05	CcSEcCtD
Alitretinoin—Mental disorder—Epirubicin—breast cancer	1.43e-05	8.4e-05	CcSEcCtD
Alitretinoin—Erythema multiforme—Doxorubicin—breast cancer	1.43e-05	8.39e-05	CcSEcCtD
Alitretinoin—Pain—Capecitabine—breast cancer	1.43e-05	8.36e-05	CcSEcCtD
Alitretinoin—Constipation—Capecitabine—breast cancer	1.43e-05	8.36e-05	CcSEcCtD
Alitretinoin—Malnutrition—Epirubicin—breast cancer	1.42e-05	8.35e-05	CcSEcCtD
Alitretinoin—Erythema—Epirubicin—breast cancer	1.42e-05	8.35e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Docetaxel—breast cancer	1.42e-05	8.32e-05	CcSEcCtD
Alitretinoin—Nausea—Fluorouracil—breast cancer	1.42e-05	8.31e-05	CcSEcCtD
Alitretinoin—Eye disorder—Doxorubicin—breast cancer	1.41e-05	8.29e-05	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—breast cancer	1.41e-05	8.28e-05	CcSEcCtD
Alitretinoin—Tinnitus—Doxorubicin—breast cancer	1.41e-05	8.27e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Docetaxel—breast cancer	1.41e-05	8.26e-05	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—breast cancer	1.41e-05	8.24e-05	CcSEcCtD
Alitretinoin—Flushing—Doxorubicin—breast cancer	1.4e-05	8.23e-05	CcSEcCtD
Alitretinoin—Flatulence—Epirubicin—breast cancer	1.4e-05	8.22e-05	CcSEcCtD
Alitretinoin—Tension—Epirubicin—breast cancer	1.4e-05	8.19e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Paclitaxel—breast cancer	1.39e-05	8.15e-05	CcSEcCtD
Alitretinoin—Nervousness—Epirubicin—breast cancer	1.38e-05	8.11e-05	CcSEcCtD
Alitretinoin—Back pain—Epirubicin—breast cancer	1.38e-05	8.07e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Capecitabine—breast cancer	1.37e-05	8.06e-05	CcSEcCtD
Alitretinoin—Angiopathy—Doxorubicin—breast cancer	1.37e-05	8.05e-05	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—breast cancer	1.37e-05	8.04e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Capecitabine—breast cancer	1.36e-05	8e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Docetaxel—breast cancer	1.36e-05	7.98e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Docetaxel—breast cancer	1.36e-05	7.98e-05	CcSEcCtD
Alitretinoin—Chills—Doxorubicin—breast cancer	1.36e-05	7.96e-05	CcSEcCtD
Alitretinoin—Arrhythmia—Doxorubicin—breast cancer	1.35e-05	7.93e-05	CcSEcCtD
Alitretinoin—Dizziness—Paclitaxel—breast cancer	1.34e-05	7.88e-05	CcSEcCtD
Alitretinoin—Vision blurred—Epirubicin—breast cancer	1.34e-05	7.87e-05	CcSEcCtD
Alitretinoin—Alopecia—Doxorubicin—breast cancer	1.34e-05	7.84e-05	CcSEcCtD
Alitretinoin—Cough—Methotrexate—breast cancer	1.33e-05	7.78e-05	CcSEcCtD
Alitretinoin—Mental disorder—Doxorubicin—breast cancer	1.32e-05	7.77e-05	CcSEcCtD
Alitretinoin—Urticaria—Capecitabine—breast cancer	1.32e-05	7.77e-05	CcSEcCtD
Alitretinoin—Ill-defined disorder—Epirubicin—breast cancer	1.32e-05	7.74e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Capecitabine—breast cancer	1.32e-05	7.73e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Capecitabine—breast cancer	1.32e-05	7.73e-05	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—breast cancer	1.32e-05	7.73e-05	CcSEcCtD
Alitretinoin—Malnutrition—Doxorubicin—breast cancer	1.32e-05	7.72e-05	CcSEcCtD
Alitretinoin—Erythema—Doxorubicin—breast cancer	1.32e-05	7.72e-05	CcSEcCtD
Alitretinoin—Anaemia—Epirubicin—breast cancer	1.31e-05	7.71e-05	CcSEcCtD
Alitretinoin—Agitation—Epirubicin—breast cancer	1.31e-05	7.67e-05	CcSEcCtD
Alitretinoin—Flatulence—Doxorubicin—breast cancer	1.3e-05	7.61e-05	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—breast cancer	1.29e-05	7.59e-05	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—breast cancer	1.29e-05	7.59e-05	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—breast cancer	1.29e-05	7.59e-05	CcSEcCtD
Alitretinoin—Tension—Doxorubicin—breast cancer	1.29e-05	7.58e-05	CcSEcCtD
Alitretinoin—Vomiting—Paclitaxel—breast cancer	1.29e-05	7.58e-05	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.29e-05	7.54e-05	CcSEcCtD
Alitretinoin—Malaise—Epirubicin—breast cancer	1.28e-05	7.53e-05	CcSEcCtD
Alitretinoin—Rash—Paclitaxel—breast cancer	1.28e-05	7.51e-05	CcSEcCtD
Alitretinoin—Dermatitis—Paclitaxel—breast cancer	1.28e-05	7.51e-05	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—breast cancer	1.28e-05	7.5e-05	CcSEcCtD
Alitretinoin—Nervousness—Doxorubicin—breast cancer	1.28e-05	7.5e-05	CcSEcCtD
Alitretinoin—Syncope—Epirubicin—breast cancer	1.28e-05	7.48e-05	CcSEcCtD
Alitretinoin—Back pain—Doxorubicin—breast cancer	1.27e-05	7.47e-05	CcSEcCtD
Alitretinoin—Headache—Paclitaxel—breast cancer	1.27e-05	7.46e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Docetaxel—breast cancer	1.27e-05	7.44e-05	CcSEcCtD
Alitretinoin—Palpitations—Epirubicin—breast cancer	1.26e-05	7.38e-05	CcSEcCtD
Alitretinoin—Confusional state—Methotrexate—breast cancer	1.25e-05	7.34e-05	CcSEcCtD
Alitretinoin—Loss of consciousness—Epirubicin—breast cancer	1.25e-05	7.34e-05	CcSEcCtD
Alitretinoin—Cough—Epirubicin—breast cancer	1.24e-05	7.28e-05	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—breast cancer	1.24e-05	7.28e-05	CcSEcCtD
Alitretinoin—Vision blurred—Doxorubicin—breast cancer	1.24e-05	7.28e-05	CcSEcCtD
Alitretinoin—Asthenia—Docetaxel—breast cancer	1.24e-05	7.25e-05	CcSEcCtD
Alitretinoin—Convulsion—Epirubicin—breast cancer	1.23e-05	7.23e-05	CcSEcCtD
Alitretinoin—Infection—Methotrexate—breast cancer	1.23e-05	7.23e-05	CcSEcCtD
Alitretinoin—Hypertension—Epirubicin—breast cancer	1.23e-05	7.21e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Capecitabine—breast cancer	1.23e-05	7.2e-05	CcSEcCtD
Alitretinoin—Ill-defined disorder—Doxorubicin—breast cancer	1.22e-05	7.17e-05	CcSEcCtD
Alitretinoin—Pruritus—Docetaxel—breast cancer	1.22e-05	7.15e-05	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—breast cancer	1.22e-05	7.14e-05	CcSEcCtD
Alitretinoin—Anaemia—Doxorubicin—breast cancer	1.22e-05	7.14e-05	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—breast cancer	1.21e-05	7.13e-05	CcSEcCtD
Alitretinoin—Chest pain—Epirubicin—breast cancer	1.21e-05	7.11e-05	CcSEcCtD
Alitretinoin—Arthralgia—Epirubicin—breast cancer	1.21e-05	7.11e-05	CcSEcCtD
Alitretinoin—Myalgia—Epirubicin—breast cancer	1.21e-05	7.11e-05	CcSEcCtD
Alitretinoin—Agitation—Doxorubicin—breast cancer	1.21e-05	7.1e-05	CcSEcCtD
Alitretinoin—Anxiety—Epirubicin—breast cancer	1.21e-05	7.08e-05	CcSEcCtD
Alitretinoin—Nausea—Paclitaxel—breast cancer	1.21e-05	7.08e-05	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—breast cancer	1.21e-05	7.07e-05	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.2e-05	7.06e-05	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methotrexate—breast cancer	1.2e-05	7.04e-05	CcSEcCtD
Alitretinoin—Discomfort—Epirubicin—breast cancer	1.2e-05	7.02e-05	CcSEcCtD
Alitretinoin—Asthenia—Capecitabine—breast cancer	1.2e-05	7.02e-05	CcSEcCtD
Alitretinoin—Malaise—Doxorubicin—breast cancer	1.19e-05	6.96e-05	CcSEcCtD
Alitretinoin—Dry mouth—Epirubicin—breast cancer	1.18e-05	6.95e-05	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—breast cancer	1.18e-05	6.94e-05	CcSEcCtD
Alitretinoin—Syncope—Doxorubicin—breast cancer	1.18e-05	6.93e-05	CcSEcCtD
Alitretinoin—Pruritus—Capecitabine—breast cancer	1.18e-05	6.92e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Docetaxel—breast cancer	1.18e-05	6.91e-05	CcSEcCtD
Alitretinoin—Confusional state—Epirubicin—breast cancer	1.17e-05	6.87e-05	CcSEcCtD
Alitretinoin—Palpitations—Doxorubicin—breast cancer	1.16e-05	6.82e-05	CcSEcCtD
Alitretinoin—Anaphylactic shock—Epirubicin—breast cancer	1.16e-05	6.81e-05	CcSEcCtD
Alitretinoin—Oedema—Epirubicin—breast cancer	1.16e-05	6.81e-05	CcSEcCtD
Alitretinoin—Hypotension—Methotrexate—breast cancer	1.16e-05	6.8e-05	CcSEcCtD
Alitretinoin—Loss of consciousness—Doxorubicin—breast cancer	1.16e-05	6.79e-05	CcSEcCtD
Alitretinoin—Infection—Epirubicin—breast cancer	1.15e-05	6.77e-05	CcSEcCtD
Alitretinoin—Cough—Doxorubicin—breast cancer	1.15e-05	6.74e-05	CcSEcCtD
Alitretinoin—Shock—Epirubicin—breast cancer	1.14e-05	6.7e-05	CcSEcCtD
Alitretinoin—Convulsion—Doxorubicin—breast cancer	1.14e-05	6.69e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Capecitabine—breast cancer	1.14e-05	6.69e-05	CcSEcCtD
Alitretinoin—Nervous system disorder—Epirubicin—breast cancer	1.14e-05	6.68e-05	CcSEcCtD
Alitretinoin—Dizziness—Docetaxel—breast cancer	1.14e-05	6.68e-05	CcSEcCtD
Alitretinoin—Thrombocytopenia—Epirubicin—breast cancer	1.14e-05	6.67e-05	CcSEcCtD
Alitretinoin—Hypertension—Doxorubicin—breast cancer	1.14e-05	6.67e-05	CcSEcCtD
Alitretinoin—Tachycardia—Epirubicin—breast cancer	1.13e-05	6.65e-05	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.13e-05	6.63e-05	CcSEcCtD
Alitretinoin—Skin disorder—Epirubicin—breast cancer	1.13e-05	6.62e-05	CcSEcCtD
Alitretinoin—Hyperhidrosis—Epirubicin—breast cancer	1.12e-05	6.59e-05	CcSEcCtD
Alitretinoin—Insomnia—Methotrexate—breast cancer	1.12e-05	6.58e-05	CcSEcCtD
Alitretinoin—Chest pain—Doxorubicin—breast cancer	1.12e-05	6.57e-05	CcSEcCtD
Alitretinoin—Arthralgia—Doxorubicin—breast cancer	1.12e-05	6.57e-05	CcSEcCtD
Alitretinoin—Myalgia—Doxorubicin—breast cancer	1.12e-05	6.57e-05	CcSEcCtD
Alitretinoin—Anxiety—Doxorubicin—breast cancer	1.12e-05	6.55e-05	CcSEcCtD
Alitretinoin—Paraesthesia—Methotrexate—breast cancer	1.11e-05	6.54e-05	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.11e-05	6.53e-05	CcSEcCtD
Alitretinoin—Discomfort—Doxorubicin—breast cancer	1.11e-05	6.5e-05	CcSEcCtD
Alitretinoin—Anorexia—Epirubicin—breast cancer	1.11e-05	6.49e-05	CcSEcCtD
Alitretinoin—Dyspnoea—Methotrexate—breast cancer	1.11e-05	6.49e-05	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—breast cancer	1.1e-05	6.47e-05	CcSEcCtD
Alitretinoin—Dizziness—Capecitabine—breast cancer	1.1e-05	6.47e-05	CcSEcCtD
Alitretinoin—Dry mouth—Doxorubicin—breast cancer	1.1e-05	6.43e-05	CcSEcCtD
Alitretinoin—Vomiting—Docetaxel—breast cancer	1.09e-05	6.42e-05	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—breast cancer	1.09e-05	6.41e-05	CcSEcCtD
Alitretinoin—Rash—Docetaxel—breast cancer	1.09e-05	6.37e-05	CcSEcCtD
Alitretinoin—Hypotension—Epirubicin—breast cancer	1.09e-05	6.37e-05	CcSEcCtD
Alitretinoin—Dermatitis—Docetaxel—breast cancer	1.08e-05	6.36e-05	CcSEcCtD
Alitretinoin—Confusional state—Doxorubicin—breast cancer	1.08e-05	6.36e-05	CcSEcCtD
Alitretinoin—Decreased appetite—Methotrexate—breast cancer	1.08e-05	6.33e-05	CcSEcCtD
Alitretinoin—Headache—Docetaxel—breast cancer	1.08e-05	6.33e-05	CcSEcCtD
Alitretinoin—Oedema—Doxorubicin—breast cancer	1.07e-05	6.3e-05	CcSEcCtD
Alitretinoin—Anaphylactic shock—Doxorubicin—breast cancer	1.07e-05	6.3e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—breast cancer	1.07e-05	6.28e-05	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—breast cancer	1.07e-05	6.28e-05	CcSEcCtD
Alitretinoin—Infection—Doxorubicin—breast cancer	1.07e-05	6.26e-05	CcSEcCtD
Alitretinoin—Pain—Methotrexate—breast cancer	1.06e-05	6.22e-05	CcSEcCtD
Alitretinoin—Vomiting—Capecitabine—breast cancer	1.06e-05	6.22e-05	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.06e-05	6.21e-05	CcSEcCtD
Alitretinoin—Shock—Doxorubicin—breast cancer	1.06e-05	6.2e-05	CcSEcCtD
Alitretinoin—Nervous system disorder—Doxorubicin—breast cancer	1.05e-05	6.18e-05	CcSEcCtD
Alitretinoin—Thrombocytopenia—Doxorubicin—breast cancer	1.05e-05	6.17e-05	CcSEcCtD
Alitretinoin—Rash—Capecitabine—breast cancer	1.05e-05	6.17e-05	CcSEcCtD
Alitretinoin—Insomnia—Epirubicin—breast cancer	1.05e-05	6.16e-05	CcSEcCtD
Alitretinoin—Dermatitis—Capecitabine—breast cancer	1.05e-05	6.16e-05	CcSEcCtD
Alitretinoin—Tachycardia—Doxorubicin—breast cancer	1.05e-05	6.15e-05	CcSEcCtD
Alitretinoin—Headache—Capecitabine—breast cancer	1.04e-05	6.13e-05	CcSEcCtD
Alitretinoin—Skin disorder—Doxorubicin—breast cancer	1.04e-05	6.12e-05	CcSEcCtD
Alitretinoin—Paraesthesia—Epirubicin—breast cancer	1.04e-05	6.12e-05	CcSEcCtD
Alitretinoin—Hyperhidrosis—Doxorubicin—breast cancer	1.04e-05	6.09e-05	CcSEcCtD
Alitretinoin—Dyspnoea—Epirubicin—breast cancer	1.04e-05	6.07e-05	CcSEcCtD
Alitretinoin—Somnolence—Epirubicin—breast cancer	1.03e-05	6.06e-05	CcSEcCtD
Alitretinoin—Anorexia—Doxorubicin—breast cancer	1.02e-05	6.01e-05	CcSEcCtD
Alitretinoin—Nausea—Docetaxel—breast cancer	1.02e-05	6e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Methotrexate—breast cancer	1.02e-05	6e-05	CcSEcCtD
Alitretinoin—Dyspepsia—Epirubicin—breast cancer	1.02e-05	6e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—breast cancer	1.01e-05	5.95e-05	CcSEcCtD
Alitretinoin—Decreased appetite—Epirubicin—breast cancer	1.01e-05	5.92e-05	CcSEcCtD
Alitretinoin—Hypotension—Doxorubicin—breast cancer	1e-05	5.89e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Epirubicin—breast cancer	1e-05	5.88e-05	CcSEcCtD
Alitretinoin—Fatigue—Epirubicin—breast cancer	1e-05	5.87e-05	CcSEcCtD
Alitretinoin—Pain—Epirubicin—breast cancer	9.93e-06	5.83e-05	CcSEcCtD
Alitretinoin—Constipation—Epirubicin—breast cancer	9.93e-06	5.83e-05	CcSEcCtD
Alitretinoin—Nausea—Capecitabine—breast cancer	9.9e-06	5.81e-05	CcSEcCtD
Alitretinoin—Urticaria—Methotrexate—breast cancer	9.86e-06	5.78e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—breast cancer	9.81e-06	5.75e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—breast cancer	9.81e-06	5.75e-05	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.79e-06	5.74e-05	CcSEcCtD
Alitretinoin—Insomnia—Doxorubicin—breast cancer	9.72e-06	5.7e-05	CcSEcCtD
Alitretinoin—Paraesthesia—Doxorubicin—breast cancer	9.65e-06	5.66e-05	CcSEcCtD
Alitretinoin—Dyspnoea—Doxorubicin—breast cancer	9.58e-06	5.62e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Epirubicin—breast cancer	9.57e-06	5.61e-05	CcSEcCtD
Alitretinoin—Somnolence—Doxorubicin—breast cancer	9.55e-06	5.6e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Epirubicin—breast cancer	9.49e-06	5.57e-05	CcSEcCtD
Alitretinoin—Dyspepsia—Doxorubicin—breast cancer	9.46e-06	5.55e-05	CcSEcCtD
Alitretinoin—Decreased appetite—Doxorubicin—breast cancer	9.34e-06	5.48e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Doxorubicin—breast cancer	9.28e-06	5.44e-05	CcSEcCtD
Alitretinoin—Fatigue—Doxorubicin—breast cancer	9.26e-06	5.43e-05	CcSEcCtD
Alitretinoin—Urticaria—Epirubicin—breast cancer	9.22e-06	5.41e-05	CcSEcCtD
Alitretinoin—Pain—Doxorubicin—breast cancer	9.19e-06	5.39e-05	CcSEcCtD
Alitretinoin—Constipation—Doxorubicin—breast cancer	9.19e-06	5.39e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Epirubicin—breast cancer	9.18e-06	5.38e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Epirubicin—breast cancer	9.18e-06	5.38e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Methotrexate—breast cancer	9.14e-06	5.36e-05	CcSEcCtD
Alitretinoin—Asthenia—Methotrexate—breast cancer	8.9e-06	5.22e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Doxorubicin—breast cancer	8.85e-06	5.19e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Doxorubicin—breast cancer	8.79e-06	5.15e-05	CcSEcCtD
Alitretinoin—Pruritus—Methotrexate—breast cancer	8.78e-06	5.15e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Epirubicin—breast cancer	8.55e-06	5.02e-05	CcSEcCtD
Alitretinoin—Urticaria—Doxorubicin—breast cancer	8.54e-06	5.01e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Doxorubicin—breast cancer	8.49e-06	4.98e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Doxorubicin—breast cancer	8.49e-06	4.98e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Methotrexate—breast cancer	8.49e-06	4.98e-05	CcSEcCtD
Alitretinoin—Asthenia—Epirubicin—breast cancer	8.33e-06	4.89e-05	CcSEcCtD
Alitretinoin—Pruritus—Epirubicin—breast cancer	8.22e-06	4.82e-05	CcSEcCtD
Alitretinoin—Dizziness—Methotrexate—breast cancer	8.2e-06	4.81e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Epirubicin—breast cancer	7.94e-06	4.66e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Doxorubicin—breast cancer	7.92e-06	4.64e-05	CcSEcCtD
Alitretinoin—Vomiting—Methotrexate—breast cancer	7.89e-06	4.63e-05	CcSEcCtD
Alitretinoin—Rash—Methotrexate—breast cancer	7.82e-06	4.59e-05	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—breast cancer	7.82e-06	4.59e-05	CcSEcCtD
Alitretinoin—Headache—Methotrexate—breast cancer	7.77e-06	4.56e-05	CcSEcCtD
Alitretinoin—Asthenia—Doxorubicin—breast cancer	7.71e-06	4.52e-05	CcSEcCtD
Alitretinoin—Dizziness—Epirubicin—breast cancer	7.68e-06	4.5e-05	CcSEcCtD
Alitretinoin—Pruritus—Doxorubicin—breast cancer	7.6e-06	4.46e-05	CcSEcCtD
Alitretinoin—Vomiting—Epirubicin—breast cancer	7.38e-06	4.33e-05	CcSEcCtD
Alitretinoin—Nausea—Methotrexate—breast cancer	7.37e-06	4.32e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Doxorubicin—breast cancer	7.35e-06	4.31e-05	CcSEcCtD
Alitretinoin—Rash—Epirubicin—breast cancer	7.32e-06	4.29e-05	CcSEcCtD
Alitretinoin—Dermatitis—Epirubicin—breast cancer	7.31e-06	4.29e-05	CcSEcCtD
Alitretinoin—Headache—Epirubicin—breast cancer	7.27e-06	4.27e-05	CcSEcCtD
Alitretinoin—Dizziness—Doxorubicin—breast cancer	7.1e-06	4.17e-05	CcSEcCtD
Alitretinoin—Nausea—Epirubicin—breast cancer	6.9e-06	4.05e-05	CcSEcCtD
Alitretinoin—Vomiting—Doxorubicin—breast cancer	6.83e-06	4.01e-05	CcSEcCtD
Alitretinoin—Rash—Doxorubicin—breast cancer	6.77e-06	3.97e-05	CcSEcCtD
Alitretinoin—Dermatitis—Doxorubicin—breast cancer	6.77e-06	3.97e-05	CcSEcCtD
Alitretinoin—Headache—Doxorubicin—breast cancer	6.73e-06	3.95e-05	CcSEcCtD
Alitretinoin—Nausea—Doxorubicin—breast cancer	6.38e-06	3.74e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism—COMT—breast cancer	3.48e-06	2.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	3.47e-06	2.65e-05	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—breast cancer	3.47e-06	2.65e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—breast cancer	3.46e-06	2.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	3.45e-06	2.63e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK3—breast cancer	3.44e-06	2.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CDA—breast cancer	3.43e-06	2.61e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SHMT1—breast cancer	3.43e-06	2.61e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMOX1—breast cancer	3.41e-06	2.6e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—breast cancer	3.41e-06	2.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ITPR1—breast cancer	3.4e-06	2.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDH7A1—breast cancer	3.39e-06	2.59e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDH1A1—breast cancer	3.39e-06	2.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.38e-06	2.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	3.37e-06	2.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	3.36e-06	2.56e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK3—breast cancer	3.36e-06	2.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.35e-06	2.55e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—breast cancer	3.34e-06	2.55e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A5—breast cancer	3.3e-06	2.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLCO1B1—breast cancer	3.3e-06	2.52e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK3—breast cancer	3.3e-06	2.51e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK3—breast cancer	3.3e-06	2.51e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	3.29e-06	2.51e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB1—breast cancer	3.28e-06	2.5e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—breast cancer	3.26e-06	2.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FHL2—breast cancer	3.25e-06	2.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UMPS—breast cancer	3.25e-06	2.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NME1—breast cancer	3.25e-06	2.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADSL—breast cancer	3.25e-06	2.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PHGDH—breast cancer	3.25e-06	2.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	3.24e-06	2.47e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.23e-06	2.46e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TYMS—breast cancer	3.22e-06	2.45e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ESR1—breast cancer	3.21e-06	2.45e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—breast cancer	3.21e-06	2.44e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—breast cancer	3.21e-06	2.44e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—breast cancer	3.19e-06	2.44e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LDHB—breast cancer	3.19e-06	2.43e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HPSE—breast cancer	3.19e-06	2.43e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BRIP1—breast cancer	3.19e-06	2.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APRT—breast cancer	3.19e-06	2.43e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NCOR1—breast cancer	3.18e-06	2.42e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—breast cancer	3.18e-06	2.42e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLA2G4A—breast cancer	3.18e-06	2.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	3.15e-06	2.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.13e-06	2.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	3.12e-06	2.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.12e-06	2.37e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH1—breast cancer	3.1e-06	2.37e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPX1—breast cancer	3.04e-06	2.32e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—breast cancer	3.04e-06	2.32e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	3.03e-06	2.31e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA3—breast cancer	3.03e-06	2.31e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMMR—breast cancer	3.03e-06	2.31e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCC1—breast cancer	3.03e-06	2.31e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—breast cancer	3.02e-06	2.3e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A1—breast cancer	3.01e-06	2.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ANGPTL4—breast cancer	3e-06	2.28e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ESRRA—breast cancer	3e-06	2.28e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ERCC2—breast cancer	2.99e-06	2.28e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—breast cancer	2.98e-06	2.27e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—breast cancer	2.98e-06	2.27e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARGC1B—breast cancer	2.93e-06	2.23e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	2.91e-06	2.22e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.87e-06	2.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.85e-06	2.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPI—breast cancer	2.84e-06	2.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HADHB—breast cancer	2.84e-06	2.17e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—breast cancer	2.81e-06	2.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.79e-06	2.13e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.78e-06	2.12e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA9—breast cancer	2.77e-06	2.11e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA4—breast cancer	2.77e-06	2.11e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.73e-06	2.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.72e-06	2.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDH1A1—breast cancer	2.71e-06	2.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDH7A1—breast cancer	2.71e-06	2.07e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA2—breast cancer	2.7e-06	2.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX2—breast cancer	2.7e-06	2.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.68e-06	2.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX4—breast cancer	2.66e-06	2.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SULT1A1—breast cancer	2.66e-06	2.03e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—breast cancer	2.64e-06	2.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA1—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—IDH1—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PHGDH—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UMPS—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADSL—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FHL2—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NME1—breast cancer	2.6e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAV1—breast cancer	2.59e-06	1.98e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—breast cancer	2.59e-06	1.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.58e-06	1.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAT2—breast cancer	2.57e-06	1.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—breast cancer	2.57e-06	1.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BRIP1—breast cancer	2.55e-06	1.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HPSE—breast cancer	2.55e-06	1.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LDHB—breast cancer	2.55e-06	1.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.48e-06	1.89e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—breast cancer	2.46e-06	1.87e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCC1—breast cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA3—breast cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMMR—breast cancer	2.42e-06	1.84e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.37e-06	1.81e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—breast cancer	2.36e-06	1.8e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—breast cancer	2.36e-06	1.8e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARGC1B—breast cancer	2.34e-06	1.78e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—breast cancer	2.32e-06	1.77e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.29e-06	1.75e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.28e-06	1.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.28e-06	1.74e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—breast cancer	2.27e-06	1.73e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MED12—breast cancer	2.26e-06	1.72e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DPYD—breast cancer	2.26e-06	1.72e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—breast cancer	2.22e-06	1.69e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—breast cancer	2.22e-06	1.69e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDOA—breast cancer	2.22e-06	1.69e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA4—breast cancer	2.21e-06	1.68e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA9—breast cancer	2.21e-06	1.68e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.18e-06	1.66e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.16e-06	1.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOA3—breast cancer	2.16e-06	1.64e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX2—breast cancer	2.15e-06	1.64e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA2—breast cancer	2.15e-06	1.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A2—breast cancer	2.14e-06	1.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX4—breast cancer	2.13e-06	1.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SULT1A1—breast cancer	2.13e-06	1.62e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CPT1A—breast cancer	2.1e-06	1.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCG2—breast cancer	2.1e-06	1.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTR—breast cancer	2.1e-06	1.6e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA1—breast cancer	2.08e-06	1.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—IDH1—breast cancer	2.08e-06	1.58e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CD—breast cancer	2.08e-06	1.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HPGDS—breast cancer	2.06e-06	1.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAT2—breast cancer	2.05e-06	1.57e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—breast cancer	2.05e-06	1.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HBA1—breast cancer	2.04e-06	1.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ACHE—breast cancer	1.99e-06	1.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—breast cancer	1.99e-06	1.52e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—breast cancer	1.96e-06	1.49e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.94e-06	1.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP17A1—breast cancer	1.89e-06	1.44e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ENO1—breast cancer	1.87e-06	1.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS1—breast cancer	1.87e-06	1.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.86e-06	1.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2D6—breast cancer	1.83e-06	1.4e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CB—breast cancer	1.81e-06	1.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MED12—breast cancer	1.8e-06	1.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DPYD—breast cancer	1.8e-06	1.37e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOA2—breast cancer	1.8e-06	1.37e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—breast cancer	1.79e-06	1.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDOA—breast cancer	1.77e-06	1.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.75e-06	1.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FASN—breast cancer	1.75e-06	1.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BCHE—breast cancer	1.74e-06	1.32e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOA3—breast cancer	1.72e-06	1.31e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK3—breast cancer	1.72e-06	1.31e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A5—breast cancer	1.72e-06	1.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A2—breast cancer	1.71e-06	1.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.69e-06	1.29e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTR—breast cancer	1.67e-06	1.28e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CPT1A—breast cancer	1.67e-06	1.28e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCG2—breast cancer	1.67e-06	1.28e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—breast cancer	1.67e-06	1.27e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NQO1—breast cancer	1.66e-06	1.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A1—breast cancer	1.66e-06	1.26e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HPGDS—breast cancer	1.64e-06	1.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HBA1—breast cancer	1.63e-06	1.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP3A4—breast cancer	1.62e-06	1.23e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ACHE—breast cancer	1.59e-06	1.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—breast cancer	1.59e-06	1.21e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1B1—breast cancer	1.59e-06	1.21e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.58e-06	1.21e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—breast cancer	1.56e-06	1.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSP90AA1—breast cancer	1.56e-06	1.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOA1—breast cancer	1.52e-06	1.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP17A1—breast cancer	1.51e-06	1.15e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP19A1—breast cancer	1.49e-06	1.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—STK11—breast cancer	1.49e-06	1.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS1—breast cancer	1.49e-06	1.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ENO1—breast cancer	1.49e-06	1.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.49e-06	1.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.47e-06	1.12e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2D6—breast cancer	1.46e-06	1.12e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOA2—breast cancer	1.44e-06	1.09e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FASN—breast cancer	1.39e-06	1.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—COMT—breast cancer	1.39e-06	1.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BCHE—breast cancer	1.39e-06	1.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—breast cancer	1.38e-06	1.05e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A5—breast cancer	1.37e-06	1.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMOX1—breast cancer	1.36e-06	1.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ITPR1—breast cancer	1.36e-06	1.04e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NQO1—breast cancer	1.32e-06	1.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A1—breast cancer	1.32e-06	1.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.3e-06	9.88e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP3A4—breast cancer	1.29e-06	9.84e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMS—breast cancer	1.29e-06	9.8e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.28e-06	9.79e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOR1—breast cancer	1.27e-06	9.69e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G4A—breast cancer	1.27e-06	9.69e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—breast cancer	1.27e-06	9.69e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1B1—breast cancer	1.27e-06	9.67e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.24e-06	9.49e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX1—breast cancer	1.22e-06	9.28e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOA1—breast cancer	1.21e-06	9.23e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A1—breast cancer	1.2e-06	9.18e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ERCC2—breast cancer	1.19e-06	9.11e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—STK11—breast cancer	1.19e-06	9.09e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP19A1—breast cancer	1.19e-06	9.09e-06	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—breast cancer	1.16e-06	8.83e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—breast cancer	1.12e-06	8.56e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.12e-06	8.54e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—COMT—breast cancer	1.11e-06	8.45e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—breast cancer	1.1e-06	8.41e-06	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—breast cancer	1.1e-06	8.41e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMOX1—breast cancer	1.09e-06	8.3e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ITPR1—breast cancer	1.09e-06	8.28e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB1—breast cancer	1.04e-06	7.97e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAV1—breast cancer	1.04e-06	7.9e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMS—breast cancer	1.03e-06	7.82e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOR1—breast cancer	1.01e-06	7.73e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.01e-06	7.73e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—breast cancer	1.01e-06	7.73e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX1—breast cancer	9.71e-07	7.4e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1A1—breast cancer	9.62e-07	7.33e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ERCC2—breast cancer	9.54e-07	7.27e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—breast cancer	9.44e-07	7.19e-06	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—breast cancer	9.01e-07	6.87e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—breast cancer	8.96e-07	6.83e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CD—breast cancer	8.29e-07	6.32e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAV1—breast cancer	8.27e-07	6.3e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—breast cancer	8.19e-07	6.24e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.9e-07	6.02e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—breast cancer	7.83e-07	5.97e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—breast cancer	7.53e-07	5.74e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CB—breast cancer	7.23e-07	5.51e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—breast cancer	7.16e-07	5.46e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CD—breast cancer	6.62e-07	5.05e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—breast cancer	6.54e-07	4.98e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—breast cancer	6.25e-07	4.77e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—breast cancer	6.25e-07	4.76e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CB—breast cancer	5.77e-07	4.4e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—breast cancer	5.72e-07	4.36e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—breast cancer	4.99e-07	3.8e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—breast cancer	4.41e-07	3.36e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—breast cancer	3.6e-07	2.74e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—breast cancer	3.52e-07	2.68e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—breast cancer	2.87e-07	2.19e-06	CbGpPWpGaD
